Connection

Rolando Cimaz to Antirheumatic Agents

Back to Details
This is a "connection" page, showing publications Rolando Cimaz has written about Antirheumatic Agents.
Rolando Cimaz
Connection Strength
1.957
Antirheumatic Agents
  1. Patients with juvenile idiopathic arthritis on TNF inhibitors exposed to COVID-19 family members. Semin Arthritis Rheum. 2020 12; 50(6):1214-1215.
    View in: PubMed
    Score: 0.296
  2. COVID-19 and what pediatric rheumatologists should know: a review from a highly affected country. Pediatr Rheumatol Online J. 2020 Apr 22; 18(1):35.
    View in: PubMed
    Score: 0.287
  3. Growth and body mass index in a cohort of patients with juvenile idiopathic arthritis: effects of second line treatments. Clin Exp Rheumatol. 2018 Sep-Oct; 36(5):929-933.
    View in: PubMed
    Score: 0.254
  4. Flares After Withdrawal of Biologic Therapies in Juvenile Idiopathic Arthritis: Clinical and Laboratory Correlates of Remission Duration. Arthritis Care Res (Hoboken). 2018 07; 70(7):1046-1051.
    View in: PubMed
    Score: 0.250
  5. Predictors of Relapse after Discontinuing Systemic Treatment in Childhood Autoimmune Chronic Uveitis. J Rheumatol. 2017 06; 44(6):822-826.
    View in: PubMed
    Score: 0.232
  6. Investigational drugs for treatment of juvenile idiopathic arthritis. Expert Opin Investig Drugs. 2017 Apr; 26(4):381-387.
    View in: PubMed
    Score: 0.231
  7. Absence of Severe Complications From SARS-CoV-2 Infection in Children With Rheumatic Diseases Treated With Biologic Drugs. J Rheumatol. 2021 08; 48(8):1343-1344.
    View in: PubMed
    Score: 0.072
  8. COVID-19 infection and rheumatoid arthritis: Faraway, so close! Autoimmun Rev. 2020 May; 19(5):102523.
    View in: PubMed
    Score: 0.071
  9. Detection of anti-adalimumab antibodies in a RA responsive cohort of patients using three different techniques. Anal Biochem. 2019 02 01; 566:133-138.
    View in: PubMed
    Score: 0.065
  10. Methotrexate in juvenile idiopathic arthritis: advice and recommendations from the MARAJIA expert consensus meeting. Pediatr Rheumatol Online J. 2018 Jul 11; 16(1):46.
    View in: PubMed
    Score: 0.063
  11. Does switching anti-TNFa biologic agents represent an effective option in childhood chronic uveitis: the evidence from a systematic review and meta-analysis approach. Semin Arthritis Rheum. 2014 Aug; 44(1):39-46.
    View in: PubMed
    Score: 0.047
  12. Recurrent pericarditis caused by a rare mutation in the TNFRSF1A gene and with excellent response to anakinra treatment. Clin Exp Rheumatol. 2010 Sep-Oct; 28(5):802.
    View in: PubMed
    Score: 0.037
  13. Defining Kawasaki disease and pediatric inflammatory multisystem syndrome-temporally associated to SARS-CoV-2 infection during SARS-CoV-2 epidemic in Italy: results from a national, multicenter survey. Pediatr Rheumatol Online J. 2021 Mar 16; 19(1):29.
    View in: PubMed
    Score: 0.019
  14. What is the true incidence of COVID-19 in patients with rheumatic diseases? Ann Rheum Dis. 2021 02; 80(2):e18.
    View in: PubMed
    Score: 0.018
  15. Treating juvenile idiopathic arthritis to target: recommendations of an international task force. Ann Rheum Dis. 2018 06; 77(6):819-828.
    View in: PubMed
    Score: 0.016
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.